First NAAT (Nucleic Acid Amplification Test) capable of delivering Trichomonas Vaginalis (TV) results from male urine specimens.
FDA-cleared for diagnosing both symptomatic and asymptomatic patients, ensuring broad applicability.
Capable of delivering positive results in as little as 40 minutes, facilitating rapid diagnosis and treatment.
Incorporates sample adequacy control to confirm the presence of human DNA, ensuring sample validity.
Part of an extensive testing menu that includes assays for CT/NG (Chlamydia/Gonorrhea) and GBS (Group B Streptococcus), all available on the same platform for streamlined laboratory operations.
Designed to deliver high-sensitivity NAAT results for accurate diagnosis of Trichomonas Vaginalis in both men and women, improving patient care.
Enables clinicians to receive same-day results, accelerating patient management decisions.
